Switching to a dual-drug regimen in hiv-infected patients could be associated with macrophage activation?

HIGHLIGHTS

  • who: Matteo Vassallo from the Department of Internal Medicine/Infectious Diseases, Cannes General Hospital, Cannes, France, Unité Recherche Université, France, Public Health Department, Hospital have published the research work: Switching to a Dual-Drug Regimen in HIV-Infected Patients Could Be Associated With Macrophage Activation?, in the Journal: (JOURNAL)
  • what: The study investigated the broadest range of inflammatory markers in HIV-infected patients simplifying their treatment.
  • how: The results are in line with those presented by Serrano-Villar et_al who recently showed that in patients switching to dual cART a delayed increase in . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?